76
Participants
Start Date
January 31, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
December 31, 2009
AC220
Powder in bottle formulation supplied as 50mg or 350 mg in glass, crimped serum vials. Requires reconstitution by a pharmacist, and must be stored securely and protected from light.
University of Alabama at Birmingham, Birmingham
University of Nebraska Medical Center, Omaha
MD Anderson Cancer Center, Houston
Chemotherapy and Immunotherapy Clinic, T'Bilisi
Hematology and Chemotherapy Clinic, T'bilisi
Lead Sponsor
Daiichi Sankyo
INDUSTRY